HomeRANI • NASDAQ
add
Rani Therapeutics Holdings Inc
Previous close
$1.57
Day range
$1.55 - $1.67
Year range
$0.39 - $3.87
Market cap
193.20M USD
Avg Volume
9.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.26M | -38.49% |
Net income | -5.41M | 20.21% |
Net profit margin | — | — |
Earnings per share | -0.12 | 50.00% |
EBITDA | -7.03M | 39.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.14M | -86.37% |
Total assets | 10.14M | -76.71% |
Total liabilities | 22.11M | -41.45% |
Total equity | -11.97M | — |
Shares outstanding | 97.54M | — |
Price to book | -9.81 | — |
Return on assets | -134.20% | — |
Return on capital | -201.08% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.41M | 20.21% |
Cash from operations | -5.06M | 39.80% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -1.01M | -113.10% |
Net change in cash | -6.07M | -2,462.03% |
Free cash flow | -4.54M | 41.43% |
About
Founded
2012
Headquarters
Website
Employees
106
